StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PVLA

Palvella Therapeutics, Inc.

PVLA Nasdaq Pharmaceutical Preparations EDGAR ↗
$140.78
-9.41 -6.27%

Key statistics

from XBRL data in SEC filings
Market cap
$2.02B
Revenue (TTM)
$1.35M
Net income (TTM)
-$49.3M
EPS (TTM)
$-4.17
P/E ratio
Dividend yield
Free cash flow
-$25.2M
Cash
$206M
Total assets
$264M
Gross margin
52-week range
$36.00 – $161.38

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 14, 2026 8-K Director or officer change Jun 30, 2026 8-K Director or officer change; Shareholder vote results Jun 16, 2026 8-K Other events May 20, 2026 8-K Other events May 15, 2026 8-K Other events May 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Apr 13, 2026 8-K Other events Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2026 8-K Entered a material agreement Feb 26, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Regulation FD disclosure Feb 24, 2026 8-K Other events Feb 24, 2026 8-K Other events Jan 29, 2026 8-K Other events Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2025 8-K Regulation FD disclosure; Other events Nov 5, 2025 8-K Regulation FD disclosure Sep 24, 2025 8-K Regulation FD disclosure Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025 8-K Regulation FD disclosure Mar 4, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Other events Dec 16, 2024 8-K Modified rights of security holders; Director or officer change; Amended charter or bylaws; Shareholder vote results; Other events Dec 12, 2024 8-K Shareholder vote results; Other events Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Other events Oct 3, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Aug 8, 2024